Really worth reading this long but fascinating article about Penn State University Researcher's groundbreaking gene therapy for cancer:
"Carl June argued for years that engineered T cells could work, without much to show for it. But thanks to the trial, people are starting to listen. Even Big Pharma wants in.
For months, Penn has been working with the Swiss pharmaceutical giant Novartis, which manufactures the cancer drug Gleevec and the ADHD drug Ritalin, among others. According to the terms of a deal struck last year, Novartis will soon construct a new building on the Penn campus, the Center for Advanced Cellular Therapies, where Penn researchers will partner with scientists from Novartis to develop the T-cell technology"
full article: http://www.phillymag.com/articles/carl-june-key-fighting-cancer/
You can also watch a short YouTube video - see our video page.